It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3419
[] Institution:Study Staff Contact – [3419] Trial:A Study of Dato-DXd Versus Investigator’s Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)